Reactive oxygen species in cancer cells: live by the sword, die by the sword
- PMID: 16959608
- DOI: 10.1016/j.ccr.2006.08.015
Reactive oxygen species in cancer cells: live by the sword, die by the sword
Abstract
Reactive oxygen species and tumor biology are intertwined in a complex web, making it difficult to understand which came first, whether oxidants are required for tumor cell growth, and whether oxidant stress can be exploited therapeutically. Evidence suggests that transformed cells use ROS signals to drive proliferation and other events required for tumor progression. This confers a state of increased basal oxidative stress, making them vulnerable to chemotherapeutic agents that further augment ROS generation or that weaken antioxidant defenses of the cell. In this respect, it appears that tumor cells may die by the same systems they require.
Comment on
-
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.Cancer Cell. 2006 Sep;10(3):241-52. doi: 10.1016/j.ccr.2006.08.009. Cancer Cell. 2006. PMID: 16959615
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources